Lalo Flores

Selected news for the person - Lalo Flores, collected since 1/2020. Recent stories appear in PR Newswire and pennsylvanialatinonews.com. We are still establishing healthcare news links for this person.

Please provide a valid email address.
Shares Healthcare News With (link):
Other Healthcare Entities

Selected Headlines

Date Headline (link) Source Relevant Snippet
6/1/2021 Century Therapeutics Adds Respected Biotech Executives to Board of Directors PR Newswire ... with 24 years of experience as an academic clinician and trialist, specialized in leading development strategy for novel immuno-oncology therapeutics."Alessandro and Kimberly each have longstanding reputations for advancing novel oncology therapeutics," said Lalo Flores , Chief Executive Officer of Century Therapeutics. "Their collective expertise in clinical immuno-oncology asset development and regulatory approval make them timely and valued additions to the Century Board of Directors during this milestone year ...
6/1/2021 PENNSYLVANIA Latino News pennsylvanialatinonews.com ... with 24 years of experience as an academic clinician and trialist, specialized in leading development strategy for novel immuno-oncology therapeutics."Alessandro and Kimberly each have longstanding reputations for advancing novel oncology therapeutics," said Lalo Flores , Chief Executive Officer of Century Therapeutics. "Their collective expertise in clinical immuno-oncology asset development and regulatory approval make them timely and valued additions to the Century Board of Directors during this milestone year ...
3/4/2021 iPSC-Derived Cell Therapy Firm, Century Scores Casdin Capital Led $160M Series C Financing vistapglobal.com ... and allow repeat dosing to provide durable responses in all patients. The team anticipates beginning clinical testing of its first products in 2022, as well as generating multiple INDs annually in the coming years. Lalo Flores , Chief Executive Officer, Century Therapeutics“We are fortunate to be surrounded by such a top-tier group of investors, whose support will enable the acceleration of Century’s technology platform into the clinic. With ...
3/10/2020 Century Therapeutics Announces Opening of Seattle Innovation Hub | Business Wire Business Wire ... the pipeline programs centered at Century’s Philadelphia headquarters. “The Innovation Hub supports not only Century’s continued pipeline growth and development, but also our expansion into Seattle, a center of excellence in cell therapies,” said Lalo Flores , Chief Executive Officer of Century Therapeutics. “I look forward to seeing the Century team grow, and am excited to have Luis and Hy leading the charge into this exciting new chapter.” Dr. Levitsky has ...
1/28/2020 Life After Novartis: Jimenez Joins Board of Bayer-Backed Cell Therapy Startup pharmavoice.com ... and operations. “We are thrilled to welcome Joe Jimenez to Century’s board of directors. His unique background, outstanding leadership, and deep understanding of the biomedical industry will complement and enrich Century,” said Century CEO Lalo Flores , Ph.D., in a statement. “His role in leading Novartis to attain the first FDA approval for a CAR T cell therapy aligns with Century’s goal to lead the next wave of innovation in cell ...
1/28/2020 Century Therapeutics Expands Board of Directors and Management Team BioSpace ... emphasis on R&D. “We are thrilled to welcome Joe Jimenez to Century’s board of directors. His unique background, outstanding leadership, and deep understanding of the biomedical industry will complement and enrich Century,” said Lalo Flores , PhD, chief executive officer at Century. “His role in leading Novartis to attain the first FDA approval for a CAR T cell therapy aligns with Century’s goal to lead the next wave of innovation ...